Trade Mark Journal No.2026/026 26 June 2026

UK00004402395 15 June 2026 (5)

Panygam

Class 5
Pharmaceutics, namely products derived from blood plasma, in particular immunoglobulins.

Octapharma AG

Representative: Withers & Rogers LLP